期刊文献+

Ki-67、p53、mdm2在中耳胆脂瘤上皮中的表达及其意义 被引量:1

Expression of Ki-67,p53 and mdm2 in middle ear cholesteatoma epithelium
暂未订购
导出
摘要 目的研究Ki-67、p53、mdm2在中耳胆脂瘤上皮细胞中的表达及其相关性,探讨其在中耳胆脂瘤发病机制中的作用。方法采用免疫组化技术检测20例后天原发性胆脂瘤中耳炎上皮组织(20耳)和8例正常外耳道皮肤上皮组织(8耳)中Ki-67、p53、mdm2蛋白的表达情况并分析其相关性。结果Ki-67在中耳胆脂瘤上皮组织中主要表达在上皮细胞的基底层、棘细胞层,颗粒层和角质层未见表达。正常外耳道皮肤中Ki-67局限表达于上皮细胞的基底层,且数量较少,分布稀疏。Ki-67在中耳胆脂瘤上皮细胞的标记指数(LI)为19.2±4.5,显著高于正常外耳道皮肤上皮细胞(6.6±2.1,t=2.247,P=0.035)。p53在中耳胆脂瘤上皮组织中主要表达于上皮细胞的基底层、棘细胞层,颗粒层和角质层散在表达。正常外耳道皮肤上皮细胞中p53未见表达或极少量表达。p53在中耳胆脂瘤上皮细胞的LI为16.5±4.1,显著高于外耳道皮肤上皮细胞(2.1±0.4,t=2.605,P=0.015)。mdm2在中耳胆脂瘤上皮组织中主要表达在上皮细胞的棘细胞层、颗粒层和角质层,在基底层细胞表达较弱。正常外耳道皮肤上皮细胞mdm2未见表达或极少量表达。mdm2蛋白在中耳胆脂瘤上皮细胞的LI为36.1±7.0,显著高于外耳道皮肤上皮细胞(1.7±0.5,t=3.325,P=0.003)。Pearson相关分析发现中耳胆脂瘤上皮细胞p53、mdm2蛋白表达存在正相关(r=0.499,P=0.031)。结论与正常外耳道皮肤上皮细胞比较,中耳胆脂瘤上皮细胞具有过度增殖的趋势。p53、mdm2异常表达与中耳胆脂瘤发生密切相关,二者在上皮细胞层的分布特性与其病理状态相关。 Objective To investigate the expressions and correlation of Ki-67, p53 and mdm2 in human middle ear cholesteatoma, and assess their potential pathogenic role in the development of middle ear cholesteatoma. Methods The protein expressions of Ki-67, p53 and mdm2 were detected with immunohistochemical methods in 20 samples of primary cholesteatoma (20 ears) and 8 control samples of skin from normal external acoustic meatus skin (8 ears), and the correlations were then analyzed. Results In the epithelial tissues of middle ear eholesteatoma, Ki-67 was expressed mainly in the basal layer of epithelial cells and stratum spinosum, and was negative in the cells of granular layer and stratum corneum. In the epithelium of external acoustic meatus, Ki-67 locally expressed in the basal layer of epithelial cells in a little amount and sparse distribution. The labeling index (LI) of Ki67 in epithelial cells of middle ear cholesteatoma was 19. 2±4. 5, significantly higher than that in the external acoustic meatus skin (6. 6±2. 1, t=2.247, P=0. 035). p53 expressed mainly in the basal layer of epithelial cells and stratum spinosum, sporadically expressed in the cells of granular layer and stratum corneum in the cholesteatoma epithelial tissue, and none or a little amount of p53 expressed in the epithelial cells of external acoustic meatus skin. The LI of p53 was 16.5±4. 1 in the cholesteatoma epithelium, which was significantly higher than that in the external acoustic meatus skin (2. 1± 0. 4, t=2. 605, P=0. 015). mdm2 was expressed mainly in the cells of spinous layer, granular layer and stratum corneum. None or a little amount of mdm2 was expressed in the epithelial cells of external acoustic meatus skin. The LI of mdm2 was 36. 1 ± 7. 0 in the cholesteatoma epithelium, and it was significantly higher than that in the external acoustic meatus skin (1.7±0. 5, t=3. 325, P=0. 003). There was positive correlation between p53 and mdm2 expression in eholesteatoma epithelium analyzed by Pearson correlation test ( r= 0. 499, P=0. 031). Conclusions The cholesteatoma epithelium displays a tendency of over proliferation compared with the normal external acoustic meatus skin. The abnormal expression of p53 and mdm2 is closely correlated with the pathogenic mechanism of cholesteatoma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2009年第9期1089-1092,共4页 Medical Journal of Chinese People's Liberation Army
关键词 胆脂瘤 中耳 KI-67抗原 肿瘤抑制蛋白质P53 原癌基因蛋白质c-mdm2 cholesteatoma middle ear Ki-67 antigen tumor suppressor protein P53 proto-oncogene proteins c-mdm2
  • 相关文献

参考文献7

  • 1Vazquez A, Bond EE, Levine AJ, et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Diseov, 2008, 7(12):979.
  • 2Feng Z, Hu W, Rajagopal G, et al. The tumor suppressor p53: cancer and aging. Cell Cycle, 2008, 7(7):842.
  • 3Ergun S, Zheng X, Carlsoo B. Antigen expression of epithelial markers, collagen Ⅳ and Ki-67 in middle ear cholesteatoma. Acta Otolaryngol, 1994, 114(3):295.
  • 4Huisrnan MA, De Heer, Grote JJ. Cholesteatorna epithelium is characterized by increased of Ki-67, p53 and p21, with minimal apoptosis. Aeta Otolaryngol, 2003, 123(3) :337.
  • 5Lev Bar-Or R, Maya R, Segel LA, et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci USA, 2000, 97(21) :11250.
  • 6Bose I, Ghosh R The p53-MDM2 network: from oscillations to ap optosis. J Biosci, 2007, 32(5):991.
  • 7汪欣,祝威,王苹,周志华,郭晓峰.中耳胆脂瘤上皮过度增殖与MDM2的相关性[J].中国耳鼻咽喉头颈外科,2005,12(10):643-644. 被引量:1

二级参考文献2

同被引文献11

  • 1Wade M,Li YC,Waht GM. MDM2,MDMX and p53 in oncogene- sis and cancer therapy[J]. Nat Rev Cancer,2013,13(2):83-96.
  • 2Li Q, Lozano G. Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy[J]. Clin Cancer Res, 2013,19 (1) : 34-41.
  • 3Iwakuma T, Agarwal N. MDM2 binding protein, a novel metasta- sis suppressor[J]. Cancer Metastasis Rev, 2012,31 (3-4) : 633-640.
  • 4Oliner JD,Kinzler KW, Meltzer PS,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas[J]. Nature, 1992,358(6381) :80-83.
  • 5Ladanyi M, Cha C, Lewis R, et al. MDM2 gene amplification in metastatic osteosarcoma[J]. Cancer Res, 1993,53 (1) : 16-18.
  • 6Mathew R, Arora S, Khanna R, et al. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer [J].Eur J Cancer,2002,38(6) :832-841.
  • 7Horie S,Endo K,Kawasaki H, et al. Overexpression of MDM2 protein in intrahepatic cholangioearcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features [J]. Virchows Arch, 2000,437 (1) :25-30.
  • 8Zhang L, Hill RP. Hypoxia enhances metastatic efficiency by up- regulating Mdm2 in KHT cells and increasing resistance to apop- tosis[J]. Cancer Res,2004,64(12) :4180-4189.
  • 9Zietz C, Rossle M, Haas C,et al. MDM-2 oncoprotein overexpres- sion,p53 gene mutation, and VEGF up-regulation in angiosarco- mas[J]. Am J Pathol, 1998,153 (5) : 1425-1433.
  • 10Ozdemir E, Kakehi Y, Okuno H, et al. Strong correlation of base- ment membrane degradation with p53 inactivation and/or MDM2 overexpression in superficial urothelial carcinomas [J]. J Urol, 1997,158(1):206-211.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部